Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

A ICOPE Intense Program Combined With Ketone Ester Pilot Study

Authors not listed

University Hospital, Toulouse · 2025

Abstract

ICOPE could constitute the reference model of care for healthy aging. More specifically, our hypothesis is that the intervention implemented in ICOPE may directly or indirectly prevent immuno-senescence(definition), the loss of mobility and the cognitive decline. In future Geroscience clinical trials, ICOPE-Intense could become a benchmark to reduce the rate of aging with a strong non-pharmacological intervention and state a reference intervention to compare with new gerotherapeutic drugs.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-07 MST

Cite this

APA
Anonymous. (2025). A ICOPE Intense Program Combined With Ketone Ester Pilot Study. <em>University Hospital, Toulouse</em>. https://clinicaltrials.gov/study/NCT07048860
Vancouver
Anonymous. A ICOPE Intense Program Combined With Ketone Ester Pilot Study. University Hospital, Toulouse. 2025.
BibTeX
@misc{anon2025AICOPE, title = {A ICOPE Intense Program Combined With Ketone Ester Pilot Study}, author = {Anonymous}, journal = {University Hospital, Toulouse}, year = {2025}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings